Lyn kinase promotes erythroblast expansion and late-stage development Journal Article


Authors: Karur, V. G.; Lowell, C. A.; Besmer, P.; Agosti, V.; Wojchowski, D. M.
Article Title: Lyn kinase promotes erythroblast expansion and late-stage development
Abstract: Lyn kinase is known to modulate the formation and function of B cells, monocytes, and mast cells. However, Lyn(-/-) mice also develop erythrosplenomegaly, and cases for both negative and positive erythropoietic actions of Lyn recently have been outlined. In phenylhydrazine-treated Lyn(-/-) mice, extramedullary splenic erythropoiesis was hyperactivated, but this did not lead to accelerated recovery from anemia. Furthermore, ex vivo analyses of the development of bone marrow-derived Lyn(-/-) erythroblasts in unique primary culture systems indicated positive roles for Lyn at 2 stages. Late-stage Lyn(-/-) erythroblasts exhibited deficit Ter119(pos) cell formation, and this was paralleled by increased apoptosis (and decreased Bcl-xL expression). During early development, Lyn(-/-) erythroblasts accumulated at a Kit(pos)CD71(high) stage, possessed decreased proliferative capacity, and were attenuated in entering an apparent G1/S cell-cycle phase. In proposed compensatory responses, Lyn(-/-) erythroblasts expressed increased levels of activated Akt and p60-Src and decreased levels of death-associated protein kinase-2. Stat5 activation and Bcl-xL expression, in contrast, were significantly decreased in keeping with decreased survival and developmental potentials. Lyn, therefore, is proposed to function via erythroid cell-intrinsic mechanisms to promote progenitor cell expansion beyond a Kit(pos)CD71(high) stage and to support subsequent late-stage development.
Keywords: mice; protein-tyrosine kinases; src-family kinases; erythropoietin receptor; signaling pathways; negative regulation; deficient; hematopoietic-cells; b-cell development; affinity ige receptor; marrow mast-cells
Journal Title: Blood
Volume: 108
Issue: 5
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2006-09-01
Start Page: 1524
End Page: 1532
Language: English
ACCESSION: WOS:000240271500022
DOI: 10.1182/blood-2005-09-008243
PROVIDER: wos
PMCID: PMC1895506
PUBMED: 16705093
Notes: --- - Article - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valter Agosti
    9 Agosti
  2. Peter Besmer
    115 Besmer